Medicare Enrolled

Dr. Mohsen Mabudian, M.D.

Allergy & Immunology · Redlands, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2 W FERN AVE, Redlands, CA 92373
9097933311
In practice since 2006 (19 years)
NPI: 1629022819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mabudian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mabudian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mabudian

Dr. Mohsen Mabudian is an allergy & immunology specialist in Redlands, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mabudian performed 110,009 Medicare services across 516 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mabudian received a total of $77,604 from 35 pharmaceutical and/or device companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mabudian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in CA $77,604 industry payments

Medicare Practice Summary

Medicare Utilization ↗
110,009
Medicare services
Top 1% in CA for allergy & immunology
516
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,790 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tezepelumab injection, 1 mg
An injection of tezepelumab-ekko, a medication administered in 1 mg doses.
24,990 $14 $55
Inclisiran injection (Leqvio) for cholesterol 20,448 $9 $35
Omalizumab injection (Xolair) for asthma/allergy 17,700 $30 $127
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
15,000 $17 $81
Injection, mepolizumab, 1 mg 12,800 $23 $99
Injection, eptinezumab-jjmr, 1 mg 9,800 $13 $50
Injection, benralizumab, 1 mg 5,250 $132 $543
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,139 $3 $13
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
1,030 $11 $45
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
777 $12 $149
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
398 $18 $107
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
326 $58 $201
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
206 $9 $26
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $96 $328
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
42 $133 $433
New patient office visit, complex (60-74 min) 27 $159 $577
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
83.6% medium
2.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$77,604
Total received (2018-2024)
Avg $11,086/year across 7 years
Top 9% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
594
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55,883 (72.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,997 (14.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,725 (13.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,531
2023
$4,851
2022
$1,514
2021
$933
2020
$5,842
2019
$21,934
2018
$39,999

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$492
GlaxoSmithKline, LLC.
$330
Takeda Pharmaceuticals U.S.A., Inc.
$323
GENZYME CORPORATION
$285
Regeneron Healthcare Solutions, Inc.
$252
CSL Behring
$142
ABBVIE INC.
$141
PFIZER INC.
$131
Pharming Healthcare, Inc.
$88
Genentech USA, Inc.
$81
BioCryst US Sales Co., LLC
$75
LEO Pharma Inc.
$66
Grifols USA, LLC
$48
X4 Pharmaceuticals, Inc.
$30
Octapharma USA, Inc.
$24
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 45.3% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$27,089
Shire North American Group Inc
$20,201
CSL Behring
$9,473
OptiNose US, Inc.
$8,743
Teva Pharmaceuticals USA, Inc.
$2,257
AstraZeneca Pharmaceuticals LP
$1,768
GlaxoSmithKline, LLC.
$1,307
Regeneron Healthcare Solutions, Inc.
$1,154
GENZYME CORPORATION
$982
Takeda Pharmaceuticals U.S.A., Inc.
$959
Pharming Healthcare, Inc.
$958
PFIZER INC.
$576
ALK-Abello, Inc
$301
BioCryst US Sales Co., LLC
$292
Optinose US, Inc.
$199
Novartis Pharmaceuticals Corporation
$145
Horizon Pharma plc
$143
ABBVIE INC.
$141
LEO Pharma Inc.
$129
Sunovion Pharmaceuticals Inc.
$107
Grifols USA, LLC
$89
Horizon Therapeutics plc
$78
Bio Products Laboratory USA, Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Kaleo, Inc.
$62
Genentech, Inc.
$48
Amgen Inc.
$44
kaleo, Inc.
$41
ADMA BioManufacturing LLC
$39
X4 Pharmaceuticals, Inc.
$30
Mylan Specialty L.P.
$25
Octapharma USA, Inc.
$24
Merck Sharp & Dohme Corporation
$20
Phadia US Inc.
$19
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 73.1% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ASMANEX · AUVI-Q · BENLYSTA · BREO · BREO ELLIPTA · BREZTRI · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ImmunoCAP · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · Odactra · PANZYGA · QVAR · RAYOS · RINVOQ · RUCONEST · SPIRIVA RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · XOLREMDI · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for allergy & immunology in CA.

Looking for an allergy & immunology specialist in Redlands?
Compare allergy & immunologists in the Redlands area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
11
Per 100K population
0.5
County median income
$82,184
Nearest hospital
REDLANDS COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mabudian is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mabudian experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Mabudian performed 24,990 tezepelumab injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mabudian receive payments from pharmaceutical companies?
Yes. Dr. Mabudian received a total of $77,604 from 35 companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mabudian's costs compare to other allergy & immunologists in Redlands?
Dr. Mabudian's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mabudian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →